Lataa...
Roxadustat and thyroid-stimulating hormone suppression
Hypoxia-inducible factor prolyl-hydroxylase inhibitors belong to a new class of orally administered drugs for treating anemia in patients with chronic kidney disease (CKD). The prevalence of hypothyroidism is disproportionately high in patients with CKD on hemodialysis. We report a rapid suppression...
Tallennettuna:
| Julkaisussa: | Clin Kidney J |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8087136/ https://ncbi.nlm.nih.gov/pubmed/33959275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfab007 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|